EP1781302A4 - Nouvelle utilisation - Google Patents

Nouvelle utilisation

Info

Publication number
EP1781302A4
EP1781302A4 EP05766728A EP05766728A EP1781302A4 EP 1781302 A4 EP1781302 A4 EP 1781302A4 EP 05766728 A EP05766728 A EP 05766728A EP 05766728 A EP05766728 A EP 05766728A EP 1781302 A4 EP1781302 A4 EP 1781302A4
Authority
EP
European Patent Office
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05766728A
Other languages
German (de)
English (en)
Other versions
EP1781302A1 (fr
Inventor
Mona Staahle
Guenther Weber
Johan Heilborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipopeptide AB
Original Assignee
Lipopeptide AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401943A external-priority patent/SE0401943D0/xx
Application filed by Lipopeptide AB filed Critical Lipopeptide AB
Publication of EP1781302A1 publication Critical patent/EP1781302A1/fr
Publication of EP1781302A4 publication Critical patent/EP1781302A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05766728A 2004-07-28 2005-07-26 Nouvelle utilisation Withdrawn EP1781302A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59161504P 2004-07-28 2004-07-28
SE0401943A SE0401943D0 (sv) 2004-07-28 2004-07-28 New use
PCT/SE2005/001184 WO2006011849A1 (fr) 2004-07-28 2005-07-26 Nouvelle utilisation

Publications (2)

Publication Number Publication Date
EP1781302A1 EP1781302A1 (fr) 2007-05-09
EP1781302A4 true EP1781302A4 (fr) 2010-02-17

Family

ID=35786492

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05766728A Withdrawn EP1781302A4 (fr) 2004-07-28 2005-07-26 Nouvelle utilisation

Country Status (4)

Country Link
EP (1) EP1781302A4 (fr)
AU (1) AU2005267629A1 (fr)
CA (1) CA2581693A1 (fr)
WO (1) WO2006011849A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE556743T1 (de) 2008-07-14 2012-05-15 Medtronic Inc Taktverwaltungsverfahren für eine implantierbare medizinische vorrichtung
JP2012519016A (ja) * 2009-02-26 2012-08-23 ジー−センス エルテーデー． 流体を貯蔵／放出する圧力容器システム
WO2016035804A1 (fr) * 2014-09-02 2016-03-10 東レ株式会社 Agent thérapeutique ou prophylactique contre des maladies de la peau provoquant des démangeaisons
WO2017209934A1 (fr) * 2016-05-13 2017-12-07 Case Western Reserve University Activateurs de l'autophagie pour le traitement ou la prévention de lésions cutanées
IT202000009388A1 (it) * 2020-04-29 2021-10-29 Steve Jones S R L Composizione per applicazione topica con attività antiinfiammatoria, antimicrobica e riparatrice

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JP2000143515A (ja) * 1998-11-16 2000-05-23 Sumitomo Pharmaceut Co Ltd 湿疹・皮膚炎群治療剤
US20010049365A1 (en) * 1998-07-16 2001-12-06 Achkar Charles C. Compositions and methods of treating abnormal cell proliferation
WO2002044403A2 (fr) * 2000-11-29 2002-06-06 Mcgill University Marqueurs destines au test d'analogues de la vitamine d et applications therapeutiques associees
WO2003018545A1 (fr) * 2001-08-22 2003-03-06 Johns Hopkins University Analogues substitues par le soufre 24 de la 1$g(a),25 dihydroxy-vitamine d¿3?
JP2004115451A (ja) * 2002-09-27 2004-04-15 Noevir Co Ltd 表皮トランスグルタミナーゼ生合成促進剤及び活性促進剤
WO2005115403A2 (fr) * 2004-05-26 2005-12-08 Cedars-Sinai Medical Center Induction de l'immunite innee par la vitamine d3 et ses analogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503922A (ja) * 1989-10-04 1993-06-24 トラスティーズ・オブ・ボストン・ユニバーシティー 創傷及び潰瘍の治癒の促進並びに歯周病の処置方法
US5610978A (en) * 1994-12-30 1997-03-11 Mitel Corporation Ring discriminator
EP1331927B1 (fr) * 2000-10-27 2007-12-12 Leo Pharma A/S Composition topique contenant au moins une vitamine d ou un analogue de vitamine d et au moins un corticosteroide
DE10161729A1 (de) * 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US20010049365A1 (en) * 1998-07-16 2001-12-06 Achkar Charles C. Compositions and methods of treating abnormal cell proliferation
JP2000143515A (ja) * 1998-11-16 2000-05-23 Sumitomo Pharmaceut Co Ltd 湿疹・皮膚炎群治療剤
WO2002044403A2 (fr) * 2000-11-29 2002-06-06 Mcgill University Marqueurs destines au test d'analogues de la vitamine d et applications therapeutiques associees
WO2003018545A1 (fr) * 2001-08-22 2003-03-06 Johns Hopkins University Analogues substitues par le soufre 24 de la 1$g(a),25 dihydroxy-vitamine d¿3?
JP2004115451A (ja) * 2002-09-27 2004-04-15 Noevir Co Ltd 表皮トランスグルタミナーゼ生合成促進剤及び活性促進剤
WO2005115403A2 (fr) * 2004-05-26 2005-12-08 Cedars-Sinai Medical Center Induction de l'immunite innee par la vitamine d3 et ses analogues

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200045, Derwent World Patents Index; AN 2000-500665, XP002558645 *
DATABASE WPI Week 200429, Derwent World Patents Index; AN 2004-310753, XP002558646 *
LANSDOWN ALAN B G: "Calcium: A potential central regulator in wound healing in the skin.", WOUND REPAIR AND REGENERATION, vol. 10, no. 5, September 2002 (2002-09-01), pages 271 - 285, XP002558644, ISSN: 1067-1927 *
See also references of WO2006011849A1 *
TIAN X Q ET AL: "1,25-Dihydroxyvitamin D3: A novel agent for enhancing wound healing", JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS INC, US, vol. 59, 1 January 1995 (1995-01-01), pages 53 - 56, XP002459131, ISSN: 0730-2312 *

Also Published As

Publication number Publication date
WO2006011849A1 (fr) 2006-02-02
EP1781302A1 (fr) 2007-05-09
CA2581693A1 (fr) 2006-02-02
AU2005267629A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
GB0522715D0 (en) New use
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
GB0421908D0 (en) New uses
EP1833808A4 (fr) Nouveaux benzothiazolesulfonamides
GB0418540D0 (en) Use
EP1781302A4 (fr) Nouvelle utilisation
GB0526552D0 (en) New use
GB0407301D0 (en) Use
GB0410015D0 (en) Use
GB0417702D0 (en) New uses
GB0412878D0 (en) Use
GB0419189D0 (en) New uses
GB0508924D0 (en) New use
GB0424494D0 (en) Use
GB0415178D0 (en) New use
GB0414091D0 (en) Use
GB0405907D0 (en) Use
IL164525A0 (en) Use
GB0418539D0 (en) Use
GB0425061D0 (en) Use
GB0404201D0 (en) Use
GB0404200D0 (en) Use
GB0405908D0 (en) Use
GB0413974D0 (en) Use
GB0413973D0 (en) Use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HEILBORN, JOHAN

Inventor name: STAHLE, MONA

Inventor name: WEBER, GUENTHER

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100114

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100413